/
/
/

UTI Asset Management Company Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)800.25
Volume (₹)29,580.00
High (₹)809.55
Upper Circuit961.85
Low (₹)798.00
Lower Circuit641.25
Prev Close801.55
52W High (₹)1,240.50
Price804.15
52W Low (₹)781.80

Share Market Cap & Key Ratios Overview

M.Cap (₹)10304.40 Cr
Div. Yield (%)4.99
PE Ratio21.45
Debt to Equity0.00
Price to Book2.70
Book Value347.24
EPS (TTM)37.38
Face Value10.00
ROE (%)10.49

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ICICIAMCNSE
HDFCAMCNSE
SBIFUNDSNSE
NAM-INDIANSE
ABSLAMCNSE
UTIAMCNSE
CRAMCNSE
IVCNSE
LTP
1W Low
1W High
Market cap (₹)
2884+177.1 (6.54%)
2718
2889.60
1,41,734Cr
2512.7+203.2 (8.80%)
2307.50
2524.70
1,04,355Cr
489.5+21.3 (4.55%)
465
490.90
98,287Cr
995.6+90.6 (10.01%)
913
1002
62,724Cr
823.55+18.05 (2.24%)
800.50
830
23,519Cr
804.15-6.25 (-0.77%)
794.40
824.90
10,304Cr
220+13.66 (6.62%)
206.78
221.88
4,330Cr
7.98+0.48 (6.40%)
7.53
8.12
249Cr

Key Highlights of UTI Asset Management Company Ltd Balance Sheet

UTI Asset Management Company Ltd balance sheet discloses shareholders' funds of ₹128.52Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹128.52Cr, and the reserves and surplus of the company is ₹3564.34Cr.

The company has its non-current liabilities with total liabilities of ₹4438.46Cr as of 2026-03-31.

The current liabilities are ₹266.74Cr as of 2026-03-31. At the same time, current assets are ₹2428.95Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹1158.54Cr and tangible assets of ₹267.9Cr, provided in the UTI Asset Management Company Ltd financial statements.